When was Magcath founded?

Magcath was founded in 2011 and raised its 1st funding round 4 years after it was founded.

Where is Magcath located?

Magcath is headquartered in Varde, Denmark.

Which legal entities is Magcath associated with?

Magcath is associated with MAGCATH APS.

How many employees does Magcath have?

As of Jun 30, 2020, the latest employee count at Magcath is 1.

Is Magcath a funded company?

Magcath is a funded company, having raised a total of $1.26M across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Dec 10, 2015.

How much is Magcath worth?

The latest valuation of Magcath is $***** as of Jan 25, 2019.

When was the latest funding round of Magcath?

Magcath's latest funding was a $***** Seed round on Jan 25, 2019, with participation from 0 investor.

Where does Magcath rank among its competitors?

Magcath ranks 35th amongst 103 active competitors, of which 30 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was Levee Medical, which secured $12M in Feb, 2026.

Who are the top competitors of Magcath?

Magcath's top competitors include Axonics, Laborie Medical and Amber Therapeutics. Among them, Levee Medical secured the most recent funding round in February, 2026.

Magcath - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Magcath is developing a device that allows women suffering from urinary stress incontinence to control when their bladder is emptied. The device consists of a soft tube that stays inserted all day.

Website: magcath.com
Email ID: *****@magcath.com

Key Metrics

Founded Year

2011

Location

Varde, Denmark

Stage

Seed

Total Funding

$1.26M in 4 rounds

Latest Funding Round

Seed, Jan 25, 2019, $*****

Post Money Valuation

$***** as on Jan 25, 2019

Investors

Seed Capital & 2 more

Ranked

35^th among 103 active competitors

Employee Count

1 as on Jun 30, 2020

Similar Companies

Laborie Medical & 39 more

View Magcath's full profile

Magcath is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
MAGCATH APS CIN: 35047565 , Denmark, Active	Feb 17, 2013	-	2 (As on Nov 30, 2024)

Magcath has raised a total funding of $1.26M over 4 rounds. Its first funding round was on Dec 10, 2015. Magcath has 2 institutional investors and 1 angel investor.

Here is the list of recent funding rounds of Magcath:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 25, 2019	1051266	Seed	1678281	2758621	7569487	8190384
Sep 13, 2017	8736920	Seed	4972295	8912962	2437882	2594432
Oct 26, 2016	7453099	Seed	4914761	2460982	6333952	6879279

Access funding benchmarks and valuations. Sign up today!

View details of Magcath's funding rounds and investors

Magcath's Board of Directors

Magcath's board has 2 active members. Niels Erikstrup is part of team and Henrik Harboe is independent board member.

Here is the list of Magcath's board of directors:

Name	Type	Representing	Status	Duration
xeyvzuz	Team	-	Past	2y 3m
bprwupk	Team	-	Past	9y 7m
Henrik Harboe	Independent board member	-	Current	10y 3m

Magcath's employee count trend

Magcath has 1 employees as of Jun 20. The total employee count is 50.0% lower than what it was in Jun 19. Here is Magcath's employee count trend over the years:

Uncover Magcath's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Magcath include Axonics, Laborie Medical and Amber Therapeutics. Here is the list of Top 10 competitors of Magcath, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Axonics 2013, Irvine (United States), Acquired	Developer of a device to control urinary and bowel movement	$143M	Advent Life Sciences, Edmond de Rothschild ... & 8 others	66/100
2nd	Laborie Medical 1967, Mississauga (Canada), Acquired	Provider of products for lower urinary tract dysfunctions in females	-	Investor, Audax Private Equity	61/100
3rd	Amber Therapeutics 2021, London (United Kingdom), Series A	Developer of bioelectrical therapies for functional disorders of the peripheral nervous system	$100M	New Enterprise Associates, F-Prime Capital ... & 5 others	57/100
4th	Levee Medical 2021, Durham (United States), Series B	Developer of urological devices for post-prostatectomy	$36.2M	-	57/100
5th	UroMems 2011, Grenoble (France), Series C	Developer of active implantable devices for urological incontinence	$85.7M	Financiere Arbevel, Wellington Partners Venture Capital ... & 14 others	57/100
6th	Valencia Technologies 2011, Santa Clarita (United States), Acquired	Developer of a coin-sized pacemaker-like device for the treatment of hypertension	$56.9M	BMG, Lifeblood Capital & 1 others	56/100
7th	Affluent Medical 2011, Paris (France), Public	Developer of minimally invasive prostheses for structural heart disease, vascular therapy, and urology	$11.7M	Truffle Capital, Hayk Holding & 8 others	56/100
8th	Fizimed 2017, Strasbourg (France), Series A	Manufacturer of device for controlling urinary leakage	$4.35M	UNIQA Group, UI Investissement & 2 others	53/100
9th	Devicare 2012, Barcelona (Spain), Series A	Developer of home solutions for diagnosis, prognosis, treatment and monitoring of chronic diseases	$7.13M	Advanced MedTech, Ona Capital & 8 others	50/100
10th	Juniper Biomedical 2019, Worcester (United States), Seed	Platform offering therapy for patients with pelvic health conditions	$2M	Auroral Holdings, Hub Angels & 3 others	48/100
35th	Magcath 2011, Varde (Denmark), Seed	Developer of smart devices to manage urinary stress incontinence	$1.26M	Seed Capital & 2 others	32/100